Drug Search Results
More Filters [+]

Pirenoxine

Alternative Names: pirenoxine
Latest Update: 2022-08-21
Latest Update Note: PubMed Publication

Product Description

Mechanisms of Action: N/A

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: Ophthalmic

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: Bulgaria | China | Hong Kong | Indonesia | Korea | Malta | Pakistan | Philippines | Portugal | Taiwan | Vietnam

Approved Indications: None

Known Adverse Events: None

Company: Guangzhou Runer Ophthalmic Biotechnology Co., Ltd./Runer Ophthalmic Pharmaceuticals (Guangzhou) Co., Ltd.
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Pirenoxine

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

Recent News Events